Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elaine P. Lunsford is active.

Publication


Featured researches published by Elaine P. Lunsford.


Nature | 2009

Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex.

Shingo Kajimura; Patrick Seale; Kazuishi Kubota; Elaine P. Lunsford; John V. Frangioni; Steven P. Gygi; Bruce M. Spiegelman

Brown adipose cells are specialized to dissipate chemical energy in the form of heat, as a physiological defence against cold and obesity. PRDM16 (PR domain containing 16) is a 140 kDa zinc finger protein that robustly induces brown fat determination and differentiation. Recent data suggests that brown fat cells arise in vivo from a Myf5-positive, myoblastic lineage by the action of PRDM16 (ref. 3); however, the molecular mechanisms responsible for this developmental switch is unclear. Here we show that PRDM16 forms a transcriptional complex with the active form of C/EBP-β (also known as LAP), acting as a critical molecular unit that controls the cell fate switch from myoblastic precursors to brown fat cells. Forced expression of PRDM16 and C/EBP-β is sufficient to induce a fully functional brown fat program in naive fibroblastic cells, including skin fibroblasts from mouse and man. Transplantation of fibroblasts expressing these two factors into mice gives rise to an ectopic fat pad with the morphological and biochemical characteristics of brown fat. Like endogenous brown fat, this synthetic brown fat tissue acts as a sink for glucose uptake, as determined by positron emission tomography with fluorodeoxyglucose. These data indicate that the PRDM16–C/EBP-β complex initiates brown fat formation from myoblastic precursors, and may provide opportunities for the development of new therapeutics for obesity and type-2 diabetes.


PLOS ONE | 2011

Mice with a Targeted Deletion of the Type 2 Deiodinase Are Insulin Resistant and Susceptible to Diet Induced Obesity

Alessandro Marsili; Cristina Aguayo-Mazzucato; Ting Chen; Aditi Kumar; Mirra Chung; Elaine P. Lunsford; John W. Harney; Thuy Van-Tran; Elena Gianetti; Waile Ramadan Md; Cyril Chou; Susan Bonner-Weir; P R Larsen; Jorge Enrique Silva; Ann Marie Zavacki

Background The type 2 iodothyronine deiodinase (D2) converts the pro-hormone thyroxine into T3 within target tissues. D2 is essential for a full thermogenic response of brown adipose tissue (BAT), and mice with a disrupted Dio2 gene (D2KO) have an impaired response to cold. BAT is also activated by overfeeding. Methodology/Principal Findings After 6-weeks of HFD feeding D2KO mice gained 5.6% more body weight and had 28% more adipose tissue. Oxygen consumption (V02) was not different between genotypes, but D2KO mice had an increased respiratory exchange ratio (RER), suggesting preferential use of carbohydrates. Consistent with this, serum free fatty acids and β-hydroxybutyrate were lower in D2KO mice on a HFD, while hepatic triglycerides were increased and glycogen content decreased. Neither genotype showed glucose intolerance, but D2KO mice had significantly higher insulin levels during GTT independent of diet. Accordingly, during ITT testing D2KO mice had a significantly reduced glucose uptake, consistent with insulin resistance. Gene expression levels in liver, muscle, and brown and white adipose tissue showed no differences that could account for the increased weight gain in D2KO mice. However, D2KO mice have higher PEPCK mRNA in liver suggesting increased gluconeogenesis, which could also contribute to their apparent insulin resistance. Conclusions/Significance We conclude that the loss of the Dio2 gene has significant metabolic consequences. D2KO mice gain more weight on a HFD, suggesting a role for D2 in protection from diet-induced obesity. Further, D2KO mice appear to have a greater reliance on carbohydrates as a fuel source, and limited ability to mobilize and to burn fat. This results in increased fat storage in adipose tissue, hepatic steatosis, and depletion of liver glycogen in spite of increased gluconeogenesis. D2KO mice are also less responsive to insulin, independent of diet-induced obesity.


Scientific Reports | 2013

Near-Infrared Fluorescence Imaging for Noninvasive Trafficking of Scaffold Degradation

Soon Hee Kim; Jeong Heon Lee; Hoon Hyun; Yoshitomo Ashitate; GwangLi Park; Kyle Robichaud; Elaine P. Lunsford; Sang Jin Lee; Gilson Khang; Hak Soo Choi

Biodegradable scaffolds could revolutionize tissue engineering and regenerative medicine; however, in vivo matrix degradation and tissue ingrowth processes are not fully understood. Currently a large number of samples and animals are required to track biodegradation of implanted scaffolds, and such nonconsecutive single-time-point information from various batches result in inaccurate conclusions. To overcome this limitation, we developed functional biodegradable scaffolds by employing invisible near-infrared fluorescence and followed their degradation behaviors in vitro and in vivo. Using optical fluorescence imaging, the degradation could be quantified in real-time, while tissue ingrowth was tracked by measuring vascularization using magnetic resonance imaging in the same animal over a month. Moreover, we optimized the in vitro process of enzyme-based biodegradation to predict implanted scaffold behaviors in vivo, which was closely related to the site of inoculation. This combined multimodal imaging will benefit tissue engineers by saving time, reducing animal numbers, and offering more accurate conclusions.


Annals of Plastic Surgery | 2013

Quantitative assessment of nipple perfusion with near-infrared fluorescence imaging.

Yoshitomo Ashitate; Bernard T. Lee; Long Ngo; Rita G. Laurence; Merlijn Hutteman; Rafiou Oketokoun; Elaine P. Lunsford; Hak Soo Choi; John V. Frangioni

AbstractPreserving the nipple-areolar complex with a nipple-sparing mastectomy improves cosmesis compared with skin-sparing mastectomy. However, complications such as necrosis of the nipple-areolar complex significantly affect cosmetic outcome. Many factors influence nipple-areolar perfusion, and no consensus currently exists on optimal incisional choice. This study evaluates 2 nipple-sparing mastectomy incision models using near-infrared fluorescence to assess perfusion quantitatively. The periareolar and radial incisions were compared with 2 control models in Yorkshire pigs (N = 6). Methylene blue and indocyanine green were injected intravenously, and near-infrared fluorescence images were recorded at 3 time points: before surgery, immediately after (0 hour), and 3 days postoperatively. Contrast-to-background ratio was used to assess perfusion. At 72 hours, radial incisions showed a statistically significantly higher perfusion compared with periareolar incisions (P < 0.05). Based on our findings, radial incisions for nipple-sparing mastectomy may be preferable due to higher perfusion; however, clinical trials are necessary for further assessment.


Clinical Cancer Research | 2012

EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors

Christopher H. Evans; Fangjun Liu; Ryan M. Porter; Regina P. O'Sullivan; Taha Merghoub; Elaine P. Lunsford; Kyle Robichaud; Frans van Valen; Stephen L. Lessnick; Mark C. Gebhardt; James W. Wells

Purpose: The Ewing sarcoma family of tumors (ESFT) comprises a group of aggressive, malignant bone, and soft tissue tumors that predominantly affect children and young adults. These tumors frequently share expression of the EWS-FLI-1 translocation, which is central to tumor survival but not present in healthy cells. In this study, we examined EWS-FLI-1 antigens for their capacity to induce immunity against a range of ESFT types. Design: Computer prediction analysis of peptide binding, HLA-A2.1 stabilization assays, and induction of cytotoxic T-lymphocytes (CTL) in immunized HLA-A2.1 transgenic mice were used to assess the immunogenicity of native and modified peptides derived from the fusion region of EWS-FLI-1 type 1. CTL-killing of multiple ESFT family members in vitro, and control of established xenografts in vivo, was assessed. We also examined whether these peptides could induce human CTLs in vitro. Results: EWS-FLI-1 type 1 peptides were unable to stabilize cell surface HLA-A2.1 and induced weak CTL activity against Ewing sarcoma cells. In contrast, peptides with modified anchor residues induced potent CTL killing of Ewing sarcoma cells presenting endogenous (native) peptides. The adoptive transfer of CTL specific for the modified peptide YLNPSVDSV resulted in enhanced survival of mice with established Ewing sarcoma xenografts. YLNPSVDSV-specific CTL displayed potent killing of multiple ESFT types in vitro: Ewing sarcoma, pPNET, Askins Tumor, and Biphenotypic sarcoma. Stimulation of human peripheral blood mononuclear cells with YLNPSVDSV peptide resulted in potent CTL-killing. Conclusions: These data show that YLNPSVDSV peptide is a promising antigen for ESFT immunotherapy and warrants further clinical development. Clin Cancer Res; 18(19); 5341–51. ©2012 AACR.


PLOS ONE | 2012

Real-Time Monitoring of Tumorigenesis, Dissemination, & Drug Response in a Preclinical Model of Lymphangioleiomyomatosis/Tuberous Sclerosis Complex

Fangbing Liu; Elaine P. Lunsford; Jingli Tong; Yoshitomo Ashitate; Summer L. Gibbs; Jane Yu; Hak Soo Choi; Elizabeth P. Henske; John V. Frangioni

Background TSC2-deficient cells can proliferate in the lungs, kidneys, and other organs causing devastating progressive multisystem disorders such as lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC). Preclinical models utilizing LAM patient-derived cells have been difficult to establish. We developed a novel animal model system to study the molecular mechanisms of TSC/LAM pathogenesis and tumorigenesis and provide a platform for drug testing. Methods and Findings TSC2-deficient human cells, derived from the angiomyolipoma of a LAM patient, were engineered to co-express both sodium-iodide symporter (NIS) and green fluorescent protein (GFP). Cells were inoculated intraparenchymally, intravenously, or intratracheally into athymic NCr nu/nu mice and cells were tracked and quantified using single photon emission computed tomography (SPECT) and computed tomography (CT). Surprisingly, TSC2-deficient cells administered intratracheally resulted in rapid dissemination to lymph node basins throughout the body, and histopathological changes in the lung consistent with LAM. Estrogen was found to be permissive for tumor growth and dissemination. Rapamycin inhibited tumor growth, but tumors regrew after the drug treatment was withdrawn. Conclusions We generated homogeneous NIS/GFP co-expressing TSC2-deficient, patient-derived cells that can proliferate and migrate in vivo after intratracheal instillation. Although the animal model we describe has some limitations, we demonstrate that systemic tumors formed from TSC2-deficient cells can be monitored and quantified noninvasively over time using SPECT/CT, thus providing a much needed model system for in vivo drug testing and mechanistic studies of TSC2-deficient cells and their related clinical syndromes.


Molecular Imaging | 2011

High-resolution computed tomography of single breast cancer microcalcifications in vivo

Kazumasa Inoue; Fangbing Liu; Jack Hoppin; Elaine P. Lunsford; Christian Lackas; Jacob Hesterman; Robert E. Lenkinski; Hirofumi Fujii; John V. Frangioni

Microcalcification is a hallmark of breast cancer and a key diagnostic feature for mammography. We recently described the first robust animal model of breast cancer microcalcification. In this study, we hypothesized that high-resolution computed tomography (CT) could potentially detect the genesis of a single microcalcification in vivo and quantify its growth over time. Using a commercial CT scanner, we systematically optimized acquisition and reconstruction parameters. Two ray-tracing image reconstruction algorithms were tested: a voxel-driven “fast” cone beam algorithm (FCBA) and a detector-driven “exact” cone beam algorithm (ECBA). By optimizing acquisition and reconstruction parameters, we were able to achieve a resolution of 104 μm full width at half-maximum (FWHM). At an optimal detector sampling frequency, the ECBA provided a 28 μm (21%) FWHM improvement in resolution over the FCBA. In vitro, we were able to image a single 300 μm X 100 μm hydroxyapatite crystal. In a syngeneic rat model of breast cancer, we were able to detect the genesis of a single microcalcification in vivo and follow its growth longitudinally over weeks. Taken together, this study provides an in vivo “gold standard” for the development of calcification-specific contrast agents and a model system for studying the mechanism of breast cancer microcalcification.


Annals of Plastic Surgery | 2012

Intraoperative prediction of postoperative flap outcome using the near-infrared fluorophore methylene blue.

Yoshitomo Ashitate; Bernard T. Lee; Rita G. Laurence; Elaine P. Lunsford; Merlijn Hutteman; Rafiou Oketokoun; Hak Soo Choi; John V. Frangioni

Abstract Methylene blue (MB) is a near-infrared fluorophore that provides a stable visual map of skin perfusion after intravenous injection. We explored the capability of MB to predict submental flap postoperative outcome using a single intraoperative measurement. Submental flaps were created in N = 15 pigs and imaged using the FLARE imaging system immediately after surgery and at 72 hours. Using the first 3 pigs, optimal MB dosing was found to be 2.0 mg/kg. Training and validation sets of 6 pigs each were then used for receiver operating characteristic analysis. In the training set, a contrast-to-background ratio (CBR) threshold of 1.24 provided the highest sensitivity and specificity to predict tissue necrosis at 72 hours. In the validation set, this threshold provided a prediction sensitivity of 95.3% and a specificity of 98.0%. We demonstrate that a single intraoperative near-infrared measurement can predict submental flap outcome at 72 hours.


nuclear science symposium and medical imaging conference | 2010

Imaging performance of two multiple-pinhole small-animal SPECT systems: Multiplexed vs. non-multiplexed data acquisition

Mi-Ae Park; Elaine P. Lunsford; Robert E. Zimmerman; Sudeepti Southekal; John V. Frangioni; Stephen C. Moore

Increasing the number of pinholes in small-animal SPECT significantly improves its count sensitivity. When the detector(s) are small, however, overlapping of projections (multiplexing) from different pinholes is unavoidable and can amplify noise in reconstructed images. We have evaluated the performance of two multi-pinhole systems, one with and one without multiplexing, for a prototypical tumor-imaging task. We prepared seven beads (∼1.8-mm diameter) to mimic tumors labeled with Tc-99m. A uniform gelatin phantom was used to simulate normal background tissue. The tumor-to-normal tissue ratio was ∼6:1, and each bead contained ∼1 μCi. The first scanner, equipped with two 0.8-mm pinholes on each of three heads (HMS-0.8), acquired only non-overlapping projections. We also scanned the phantom using 1.6mm pinholes (HMS-1.6) The second scanner had 9 pinholes on each of four heads, and allowed multiplexing. To compensate for decay, the phantom was scanned for 50 min on HMS-0.8, 58 min on HMS-1.6, 82 min on NanoSPECT/CT with 1.4 mm pinholes (Nano-1.4), and 102 min with 1.0 mm pinholes (Nano-1.0). A total of 30 (24) angular projections were acquired with HMS (Nano); these were reconstructed using 10 OSEM subsets for HMS, and 4 subsets for Nano. The mean voxel value in each sphere, and the mean and standard deviation in a large VOI in the background, were used to compute the signal-to-noise ratio (SNR) and contrast of each bead. The relative noise in the background was also calculated. The systems with and without multiplexing yielded similar image quality and average bead SNR, especially for HMS-0.8 and Nano-1.0. Both systems yielded very similar SNR values, despite the fact that the multiplexed system acquired data using 36 pinholes, while the non-multiplexed system had only 6 pinholes. The multiplexed acquisition did not seem to adversely affect the image contrast of the spherical tumors.


Cancer Discovery | 2012

Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer

Ashish Juvekar; Laura N. Burga; Hai Hu; Elaine P. Lunsford; Yasir H. Ibrahim; Judith Balmaña; Anbazhagan Rajendran; Antonella Papa; Katherine Spencer; Costas A. Lyssiotis; Caterina Nardella; Pier Paolo Pandolfi; José Baselga; Ralph Scully; John M. Asara; Lewis C. Cantley; Gerburg Wulf

Collaboration


Dive into the Elaine P. Lunsford's collaboration.

Top Co-Authors

Avatar

John V. Frangioni

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoshitomo Ashitate

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Fangbing Liu

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Bernard T. Lee

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rafiou Oketokoun

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Rita G. Laurence

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Robert E. Lenkinski

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Merlijn Hutteman

Leiden University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge